Xeris Biopharma Holdings XERS
NASDAQ XERS
$16.52 +0.69 (+4.36%)
At close: Nov 11, 2026 · 4:00 PM EST

Xeris Biopharma Holdings (XERS) Other Working Capital Changes (2020 - 2026)

Updated

Xeris Biopharma Holdings (XERS) recorded Other Working Capital Changes of $6.06 million in Q2 2026, down 5.4% from $6.41 million a year earlier but up 372.1% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Other Working Capital Changes (2020 - 2026) Analysis & Trends

On a TTM basis, Xeris Biopharma Holdings' Other Working Capital Changes came in at $13.19 million as of Jun 30, 2026, up 56.7% year-over-year; for FY2025, it was $16.44 million, up 627.6% from FY2024.

  • Annual Other Working Capital Changes has a five-year compound annual growth rate of 12.3% (FY2020 to FY2025).
  • Across earlier years, Other Working Capital Changes came in at $2.26 million in FY2024 (-88.4%), $19.47 million in FY2023 (+191.8%), $6.67 million in FY2022 (-10.2%) and $7.43 million in FY2021 (-19.5%).
  • Quarterly Other Working Capital Changes has ranged from -$1.99 million in Q4 2024 to $8.01 million in Q2 2023 over the past five years.
  • On a year-over-year basis, Other Working Capital Changes rose in two of the last four quarters, with growth averaging 177.4%.
  • Peak year-over-year performance for Other Working Capital Changes in the last five years was growth of 721.2% in Q1 2025, against a decline of 91.2% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.28 million (Q1 2026), -$956,000 (Q4 2025) and $6.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Xeris Biopharma Holdings 2.89 Bn 2.41 Bn 94.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 11.76 Mn
Jun 30, 2026 6.06 Mn
Mar 31, 2026 1.28 Mn
Dec 31, 2025 -822,000.00
Sep 30, 2025 6.66 Mn
Jun 30, 2025 6.41 Mn
Mar 31, 2025 4.19 Mn
Dec 31, 2024 -1.99 Mn
Sep 30, 2024 -188,000.00
Jun 30, 2024 3.93 Mn
Mar 31, 2024 510,000.00
Dec 31, 2023 3.32 Mn
Sep 30, 2023 7.32 Mn
Jun 30, 2023 8.01 Mn
Mar 31, 2023 823,000.00
Dec 31, 2022 4.37 Mn
Sep 30, 2022 3.29 Mn
Jun 30, 2022 376,000.00
Mar 31, 2022 -1.36 Mn
Dec 31, 2021 6.68 Mn
API Access

Xeris Biopharma Holdings Other Working Capital Changes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-working-capital-changes&ticker=XERS&period=max&api_key=YOUR_API_KEY